Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128886) titled 'Aspirin Prophylaxis for Preeclampsia' on July 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Province Hospital for Women and Children Healthcare
Condition:
Preeclampsia
Eclampsia
HELLP syndrome
Intervention:
experimental group(150mg):Preventive treatment consisted of 150 mg aspirin taken orally after breakfast each day, with regular monitoring throughout the study period.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-31
Target Sample Size: experimental group(150mg):725;Control group(100mg):725;
Countries of Recruitment:
China
...